RCHA Financials 07/16/2014 16:48:52 Rich Pharmace
Post# of 50
Rich Pharmaceuticals, Inc.
Period Ending Mar 31, 2013 Mar 31, 2012 Mar 31, 2011
Total Revenue - - -
Cost of Revenue - - -
Gross Profit - - -
Operating Expenses
Research and Development - - -
Sales, General and Admin. 31 32 -
Non-Recurring Items - - -
Other - - -
Operating Income (31) (32) -
Income From Continuing Operations
Add'l Income/Expense Items - - -
Earnings Before Interest and Tax (31) (32) -
Interest Expense - - -
Earnings Before Tax (31) (32) -
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (31) (32) -
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (31) (32) -
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (31) (32) -